Repligen Corporation is a company in the U.S. stock market and it is a holding in 75 U.S.-traded ETFs. RGEN has around 6.7M shares in the U.S. ETF market. The largest ETF holder of RGEN is the iShares Core S&P Mid-Cap ETF (IJH), with approximately 1.35M shares. Investors may also find of interest that the ETF with the largest allocation to RGEN stock is Invesco DWA Healthcare Momentum ETF (PTH), with a portfolio weight of 2.84%. On average, U.S. ETFs allocate 0.28% of RGEN to their portfolios.
Additionally, RGEN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with RGEN as a holding is the Invesco S&P Midcap Momentum ETF (XMMO), with a return of 20.14%.